Is the UK's 2017 drug strategy fit for purpose?
BMJ
.
2017 Sep 29:358:j4405.
doi: 10.1136/bmj.j4405.
Authors
Chris Ford
1
,
David Nutt
2
,
Niamh Eastwood
3
,
Deborah Gold
4
,
John Jolly
5
,
Fionnuala Murphy
6
,
Kate Halliday
7
,
Jamie Bridge
8
Affiliations
1
International Doctors for Healthier Drug Policies, London NW1 0JH, UK.
2
Drug Science, London SW8 1GB, UK.
3
Release, London EC1V 2NJ, UK.
4
National AIDS Trust, London EC1V 9FR, UK.
5
Blenheim CDP, London SW8 2JU, UK.
6
Harm Reduction International, London SE1 6LN, UK.
7
Substance Misuse Management Good Practice (SMMGP), Box 200, London SW19 1LJ, UK.
8
International Drug Policy Consortium, London EC1V 2NJ, UK.
PMID:
28963111
DOI:
10.1136/bmj.j4405
No abstract available
Publication types
Letter
Comment